Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
Demis Hassabis, a childhood chess prodigy, said his experience with the game afforded him his first brush with AI. He was ...
Google’s artificial intelligence arm DeepMind has been holding back the release of its world-renowned research, as it seeks ...
Google DeepMind CEO Demis Hassabis's AI journey had an unexpected start: his early mastery of chess. Years before Hassabis ...
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...
Google’s DeepMind is reportedly holding back from publishing AI research papers over fears of losing its competitive edge.
Demis, who was last year jointly awarded the Nobel Prize in Chemistry with Google DeepMind colleague Dr John Jumper for their ...
Google DeepMind CEO Demis Hassabis predicts the emergence of artificial general intelligence (AGI) within five to ten years. He acknowledges the curre ...
It was a bold choice to host a preview screening of The Thinking Game, a documentary about AI company Google DeepMind and its ...